[{"arm_notes": "New Type treatment : Single-stranded, 5\u2019-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the v", "treatment_id": null, "treatment_name": "Single-stranded, 5\u2019-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the v", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Single-stranded, 5\u2019-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the v", "treatment_id": null, "treatment_name": "Single-stranded, 5\u2019-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the v", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Chimpanzee Adenovirus encoding the SARS-CoV-2 Spike glycoprotein (ChAdOx1-S)", "treatment_id": null, "treatment_name": "Chimpanzee Adenovirus encoding the SARS-CoV-2 Spike glycoprotein (ChAdOx1-S)", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Cilgavimab+Tixagevimab", "treatment_id": null, "treatment_name": "Cilgavimab+Tixagevimab", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)", "treatment_id": null, "treatment_name": "Adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}]

[{"arm_notes": "New Type treatment : Single-stranded, 5\u2019-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the v", "treatment_id": null, "treatment_name": "Single-stranded, 5\u2019-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the v", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Chimpanzee Adenovirus encoding the SARS-CoV-2 Spike glycoprotein (ChAdOx1-S)", "treatment_id": null, "treatment_name": "Chimpanzee Adenovirus encoding the SARS-CoV-2 Spike glycoprotein (ChAdOx1-S)", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)", "treatment_id": null, "treatment_name": "Adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S)", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "New Type treatment : Single-stranded, 5\u2019-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the v", "treatment_id": null, "treatment_name": "Single-stranded, 5\u2019-capped messenger RNA (mRNA) produced using a cell-free in vitro transcription from the corresponding DNA templates, encoding the v", "treatment_type": "", "pharmacological_treatment": "Pharmacological treatment"}]

[{"arm_notes": "Third dose", "treatment_id": 222, "treatment_name": "Bnt162b2", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Third dose", "treatment_id": 824, "treatment_name": "Mrna-1273", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Third dose", "treatment_id": 24, "treatment_name": "Ad26.cov2.s", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "Third dose", "treatment_id": 161, "treatment_name": "Chadox1 ncov-19", "treatment_type": "Non replicating viral vector", "pharmacological_treatment": "Vaccine"}]